NCT01547312: Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) |
|
|
| Withdrawn | 1 | 0 | US | Peg-Interferon, PegIntron, Liver Samples from FNA, Liver Samples from CNB, Blood Samples, Ribavirin, Rebetol, 800 mg Grazoprevir, 100 mg Grazoprevir, Liver samples from CNB and FNA | Merck Sharp & Dohme LLC | Chronic Hepatitis C | 11/12 | 11/12 | | |